OpenAI has launched Rosalind, an AI model designed to support research and discovery in life sciences.
Nvidia and Eli Lilly have announced a $1 billion investment to set up a joint AI research lab focused on accelerating drug discovery.
TCS launches an AI platform to improve clinical trial oversight, quality management and decision-making for global life sciences and healthcare organisations.
